Serum Proteomic Profile Based on the TGF-Beta Pathway Stratifies Risk of Hepatocellular Carcinoma

By afschroeder • September 9, 2025

Xiang X, Shetty K, Yu H, Mishra B, Wong LL, Zhou XJ, Satapathy SK, Crawford JM, Latham PS, Han SH, Mathew B, Dagher NN, Lau L, Cacaj F, Vegesna AK, Dasarathy S, He AR, Huang H, Amdur RL, Mishra L. Serum Proteomic Profile Based on the TGF-β Pathway Stratifies Risk of Hepatocellular Carcinoma. Liver Int. 2025 Oct;45(10):e70325. doi: 10.1111/liv.70325. PMID: 40919824; PMCID: PMC12416123.

Tags: Cirrhosis, Digestive Diseases, early diagnosis, liver cancer, proteomics, Publications, surveillance

Fraudulent and Imposter Participants in Qualitative Research: Experiences from Two Multi-Site Studies

Harden D, Rodriguez N, Roybal K, Coffin T, Johnson G, Le Beaux K, Connolly M, Rountree J, Ukaegbu C, Revette AC, Nava-Coulter B, Caruso A,[...]

Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): consensus on obesity and cardiometabolic comorbidities in inflammatory bowel disease using systematic reviews and the RAND/UCLA appropriateness method

Devi J, Samaan S, Sehgal P, Mohamed M, Vincent M, Coombs S, Doering M, Barnes EL, Johnson AM, Yarur AJ, Deepak P. Modulate Obesity and[...]

Gut microbial differences and function in infants with gastroschisis: a pilot prospective cohort study

Strobel KM, Leibel SL, Bhute S, Aja E, Jacobs JP, Calkins K. Gut microbial differences and function in infants with gastroschisis: a pilot prospective cohort[...]